骨科
經濟效益
Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). （開啟新視窗）
來源: Transfusion 2008;48(2):237-50.
檢索: PubMed 18005329
DOI碼: 10.1111/j.1537-2995.2007.01515.x
Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. （開啟新視窗）
來源: Orthop Traumatol Surg Res 2012;98(5):477-83.
檢索: PubMed 22854336
DOI碼: 10.1016/j.otsr.2012.05.002
Safety, cost savings, simplicity back broader use of bloodless surgery. （開啟新視窗）
來源: OR Manager 2013;29(5):1, 6, 8-9.
檢索: PubMed 23755462
Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. （開啟新視窗）
來源: Transfusion 2011;51(1):118-24.
檢索: PubMed 20624257
DOI碼: 10.1111/j.1537-2995.2010.02783.x
Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. （開啟新視窗）
來源: Int Orthop 2019;43(12):2707-14.
檢索: PubMed 30671601
DOI碼: 10.1007/s00264-019-04291-4
Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. （開啟新視窗）
來源: J Arthroplasty 2014;29(8):1512-5.
檢索: PubMed 24630599
DOI碼: 10.1016/j.arth.2014.01.031